Milka Koupenova1, Eric Mick2, Ekaterina Mikhalev2, Emelia J Benjamin2, Kahraman Tanriverdi2, Jane E Freedman2. 1. From the Division of Cardiovascular Medicine, Department of Medicine (M.K., E. Mikhalev, K.T., J.E.F.) and Department of Quantitative Health Sciences (E. Mick), University of Massachusetts Medical School, Worcester; Department of Medicine (E.J.B.) and Whitaker Cardiovascular Institute (E.J.B.), Boston University School of Medicine, MA; and NHLBI and Boston University's Framingham Heart Study, MA (E.J.B.). milka.koupenova@umassmed.edu. 2. From the Division of Cardiovascular Medicine, Department of Medicine (M.K., E. Mikhalev, K.T., J.E.F.) and Department of Quantitative Health Sciences (E. Mick), University of Massachusetts Medical School, Worcester; Department of Medicine (E.J.B.) and Whitaker Cardiovascular Institute (E.J.B.), Boston University School of Medicine, MA; and NHLBI and Boston University's Framingham Heart Study, MA (E.J.B.).
Abstract
OBJECTIVE: Platelets contribute to thrombosis, and platelet toll-like receptors (TLRs) are central in pathogen detection, potentially mediating infection-induced vascular occlusion. Using a large community-based cohort study, we sought to examine if platelets express all known TLR transcripts and analyze their association with cardiovascular risk factors. APPROACH AND RESULTS: mRNA levels for TLRs were measured in isolated platelets by high-throughput quantitative reverse transcriptase polymerase chain reaction in 1625 participants (mean age, 66.6±9; 54% women) of the Framingham Heart Study. We measured circulating inflammatory and thrombotic markers (C-reactive protein, interleukin-6, monocyte chemoattractant protein 1, intracellular cell adhesion molecule 1, soluble tumor necrosis factor-α receptor 1, and soluble p-selectin) and analyzed TLRs and their association with sex and cardiovascular risk factors by multivariable logit regression model adjusted for confounding factors. Platelets expressed all 10 TLR transcripts, and all TLRs were coexpressed. Women had higher platelet TLR expression, which associated with different cardiovascular risk factors, compared with men. In women, TLR1, TLR3, TLR6, and TLR7 were associated with body mass index and TLR5, TLR7, and TLR10 were associated with total cholesterol to high-density lipoprotein ratio. In men, TLR1, TLR2, and TLR3 were associated with lipid and TLR8 with hypertension treatment. Similarly, TLR expression in men was more commonly associated with circulating inflammatory markers (soluble tumor necrosis factor-α receptor 1 and intracellular cell adhesion molecule 1), whereas in women, TLR expression was associated with soluble p-selectin levels. CONCLUSIONS: We report the first study to demonstrate that platelets express all TLR transcripts using a large community-based observational cohort. These transcripts are more abundant in women and have distinct associations with cardiovascular risk and inflammatory biomarkers that vary by sex.
OBJECTIVE: Platelets contribute to thrombosis, and platelet toll-like receptors (TLRs) are central in pathogen detection, potentially mediating infection-induced vascular occlusion. Using a large community-based cohort study, we sought to examine if platelets express all known TLR transcripts and analyze their association with cardiovascular risk factors. APPROACH AND RESULTS: mRNA levels for TLRs were measured in isolated platelets by high-throughput quantitative reverse transcriptase polymerase chain reaction in 1625 participants (mean age, 66.6±9; 54% women) of the Framingham Heart Study. We measured circulating inflammatory and thrombotic markers (C-reactive protein, interleukin-6, monocyte chemoattractant protein 1, intracellular cell adhesion molecule 1, soluble tumor necrosis factor-α receptor 1, and soluble p-selectin) and analyzed TLRs and their association with sex and cardiovascular risk factors by multivariable logit regression model adjusted for confounding factors. Platelets expressed all 10 TLR transcripts, and all TLRs were coexpressed. Women had higher platelet TLR expression, which associated with different cardiovascular risk factors, compared with men. In women, TLR1, TLR3, TLR6, and TLR7 were associated with body mass index and TLR5, TLR7, and TLR10 were associated with total cholesterol to high-density lipoprotein ratio. In men, TLR1, TLR2, and TLR3 were associated with lipid and TLR8 with hypertension treatment. Similarly, TLR expression in men was more commonly associated with circulating inflammatory markers (soluble tumor necrosis factor-α receptor 1 and intracellular cell adhesion molecule 1), whereas in women, TLR expression was associated with soluble p-selectin levels. CONCLUSIONS: We report the first study to demonstrate that platelets express all TLR transcripts using a large community-based observational cohort. These transcripts are more abundant in women and have distinct associations with cardiovascular risk and inflammatory biomarkers that vary by sex.
Authors: Graciela Andonegui; Steven M Kerfoot; Kelly McNagny; Kirsten V J Ebbert; Kamala D Patel; Paul Kubes Journal: Blood Date: 2005-06-16 Impact factor: 22.113
Authors: Jesse W Rowley; Andrew J Oler; Neal D Tolley; Benjamin N Hunter; Elizabeth N Low; David A Nix; Christian C Yost; Guy A Zimmerman; Andrew S Weyrich Journal: Blood Date: 2011-05-19 Impact factor: 22.113
Authors: James A de Lemos; David A Morrow; Michael A Blazing; Petr Jarolim; Stephen D Wiviott; Marc S Sabatine; Robert M Califf; Eugene Braunwald Journal: J Am Coll Cardiol Date: 2007-11-13 Impact factor: 24.094
Authors: M G Netea; A Hijmans; S van Wissen; T J Smilde; M D Trip; B J Kullberg; T de Boo; J W M Van der Meer; J J P Kastelein; A F H Stalenhoef; A F H Stalenhorf Journal: Eur J Clin Invest Date: 2004-02 Impact factor: 4.686
Authors: Kristina Edfeldt; Anna M Bennet; Per Eriksson; Johan Frostegård; Björn Wiman; Anders Hamsten; Göran K Hansson; Ulf de Faire; Zhong-qun Yan Journal: Eur Heart J Date: 2004-08 Impact factor: 29.983
Authors: Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Tony Dans; Alvaro Avezum; Fernando Lanas; Matthew McQueen; Andrzej Budaj; Prem Pais; John Varigos; Liu Lisheng Journal: Lancet Date: 2004 Sep 11-17 Impact factor: 79.321
Authors: Sean E DeWolf; Alana A Shigeoka; Andrew Scheinok; Sashi G Kasimsetty; Alexander K Welch; Dianne B McKay Journal: Nephron Date: 2017-06-15 Impact factor: 2.847
Authors: Vanessa Dela Justina; Fernanda R Giachini; Jennifer C Sullivan; R Clinton Webb Journal: J Cardiovasc Pharmacol Date: 2020-09 Impact factor: 3.105
Authors: Petrus Linge; Paul R Fortin; Christian Lood; Anders A Bengtsson; Eric Boilard Journal: Nat Rev Rheumatol Date: 2018-03-21 Impact factor: 20.543